• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR MITRACLIP SYSTEM CLIP DELIVERY SYSTEM NT; VALVE REPAIR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR MITRACLIP SYSTEM CLIP DELIVERY SYSTEM NT; VALVE REPAIR Back to Search Results
Catalog Number CDS0502
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hematoma (1884); Hypersensitivity/Allergic reaction (1907); Renal Failure (2041); Weakness (2145); Test Result (2695)
Event Date 01/27/2020
Event Type  Injury  
Manufacturer Narrative
The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot that would have contributed to this event.The reported patient effect of hematoma, hypersensitivity, weakness, renal failure and test result as listed in the mitraclip system instructions for use, are known possible complications associated with mitraclip procedures.The investigation was unable to determine a conclusive cause for the hematoma, renal failure and hypersensitivity.The reported weakness and test results appear to be cascading effects of the renal failure.There is no indication of a product issue with respect to manufacture, design, or labeling.
 
Event Description
This is filed to report the allergic reaction.It was reported that the initial mitraclip procedure was performed on (b)(6) 2019 to treat functional mitral regurgitation (mr) with an mr grade of 3-4.One clip was implanted, reducing mr to 1.On (b)(6) 2020, the patient acquired von willebrand syndrome, manifested as generalized purpura and epistaxis lasting > 1 day.Steroids were provided for treatment.On (b)(6) 2020, the patient presented with unexplained muscle weakness and renal impairment and was readmitted to the hospital from the rehabilitation hospital.Test results showed hypoalbuminemia, positive direct coombs, increased eosinophils, and increased immunoglobulin e (ige).Per the physician the possibility of allergy caused by the mitraclip device cannot be ruled out as a cause of eosinophilia or ige elevation.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MITRACLIP SYSTEM CLIP DELIVERY SYSTEM NT
Type of Device
VALVE REPAIR
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005070406
3885 bohannon drive
menlo park CA 94025
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key9980009
MDR Text Key189706144
Report Number2024168-2020-03776
Device Sequence Number1
Product Code NKM
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P100009
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Reporter Occupation Physician
Type of Report Initial
Report Date 04/20/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date06/30/2020
Device Catalogue NumberCDS0502
Device Lot Number90629U183
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/02/2020
Initial Date FDA Received04/20/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/01/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age70 YR
Patient Weight43
-
-